Stacia Chan

3PUBLICATIONS
29CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Mar 25, 2026
Farnesyl transferase inhibitor KO-2806 (darlifarnib) enhances the anti-tumor activity of tyrosine kinase inhibitors in RCC.

Jovylyn G Gasendo, Stacia Chan, Hetika V Patel

|Feb 09, 2026
The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition.

Hetika Vora Patel, Alison Elizabeth Smith, Stacia Chan

|Jun 20, 2023
Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity.

Alison E Smith, Stacia Chan, Zhiyong Wang

Pageof 1

Frequent Collaborators

3 joint publications

Alison Elizabeth Smith

3 joint publications

Hetika Vora Patel

3 joint publications

Linda Kessler

3 joint publications

Shivani Malik

3 joint publications

Francis Burrows

2 joint publications

Yahu A Liu

2 joint publications

Jovylyn Gatchalian Gasendo

2 joint publications

Amitava Mitra

1 joint publications

Zhiyong Wang

1 joint publications

Jayden Z Wang

Frequent Collaborators

3 joint publications

Alison Elizabeth Smith

3 joint publications

Hetika Vora Patel

3 joint publications

Linda Kessler

3 joint publications

Shivani Malik

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.7K
Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>
08:12

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>

Published on : Oct 05, 2020

3.4K
Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

1.3K
See more related videos

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.7K
Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>
08:12

Identification of EGFR and RAS Inhibitors using <em>Caenorhabditis elegans</em>

Published on : Oct 05, 2020

3.4K
Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

1.3K
See more related videos